Revenue | ₹125.98Cr |
Net Profits | ₹17.83Cr |
Net Profit Margins | 14.15% |
Senores Pharmaceuticals Ltd’s revenue jumped 20.67% since last year same period to ₹125.98Cr in the Q4 2024-2025. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated 16.45% jump in its revenue since last 3-months.
Senores Pharmaceuticals Ltd’s net profit jumped 11.86% since last year same period to ₹17.83Cr in the Q4 2024-2025. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated 3.78% jump in its net profits since last 3-months.
Senores Pharmaceuticals Ltd’s net profit margin fell -7.3% since last year same period to 14.15% in the Q4 2024-2025. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated -10.88% fall in its net profit margins since last 3-months.
The revenue for Senores Pharmaceuticals Ltd in the Q4 results 2024 was ₹125.98Cr.
The net profit for Senores Pharmaceuticals Ltd in the Q4 results 2024 was ₹17.83Cr.
The net profit margin for Senores Pharmaceuticals Ltd in the Q4 results 2024 was 14.15%.
The revenue for Senores Pharmaceuticals Ltd in the Q4 results 2023 was ₹104.40Cr.
The net profit for Senores Pharmaceuticals Ltd in the Q4 results 2023 was ₹15.94Cr.
The net profit margin for Senores Pharmaceuticals Ltd in the Q4 results 2023 was 15.27%.